SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001126234-17-000030
Filing Date
2017-03-31
Accepted
2017-03-31 12:55:29
Documents
7
Period of Report
2017-05-12
Effectiveness Date
2017-03-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a-2017.htm DEF 14A 1209929
2 a02jlxbnewlinkgeneticsco001.jpg GRAPHIC 206915
3 a02jlxbnewlinkgeneticsco002.jpg GRAPHIC 94587
4 def14a-2017_chartx43528.jpg GRAPHIC 18451
5 def14a-2017_chartx44581.jpg GRAPHIC 19303
6 def14a-2017_chartx45390.jpg GRAPHIC 35528
7 def14a-2017_chartx46988.jpg GRAPHIC 33421
  Complete submission text file 0001126234-17-000030.txt   1760717
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35342 | Film No.: 17729280
SIC: 2834 Pharmaceutical Preparations